|
Class 3 Device Recall |
 |
Date Initiated by Firm |
October 20, 2004 |
Date Posted |
December 16, 2004 |
Recall Status1 |
Terminated 3 on February 01, 2005 |
Recall Number |
Z-0322-05 |
Recall Event ID |
30443 |
Product Classification |
Antisera, Fluorescent, Brucella Spp. - Product Code GSM
|
Product |
BD, Brucella Postive Control Antiserum (AMS) |
Code Information |
Catalogue #240934, Lot #3210932 |
Recalling Firm/ Manufacturer |
BD Diagnostic Systems 1475 Athens Hwy Grayson GA 30017-1538
|
For Additional Information Contact |
Gail M. Claiborne 410-316-4054
|
Manufacturer Reason for Recall |
Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions.
|
FDA Determined Cause 2 |
Other |
Action |
Consignees were notified by letter beginning 10/20/2004. |
Quantity in Commerce |
100 vials (5ml per vial) |
Distribution |
Nationwide, Australia, Belgium, Canada, Chile, Ecuador, India, Korea, Malaysia, New Zealand, Singapore, Taiwan |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|